Research Groups and R&D Platforms: Biomarker

Research Group:
Computational Biomedicine and Bioinformatics

Laura Elo
laura.elo[at]btk.fi

Turku Centre for Biotechnology,
University of Turku

Laura Elo

Computational Biomedicine

Bioinformatics

Autoimmune diseases, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Diabetes, Diagnostics, Epigenomics, Genomics, Imaging, Machine learning, Metabolic diseases, Molecular diagnostics, Next-generation sequencing, Pattern recognition, Personalized medicine, Proteomics, Systems Biology, Target discovery

Research Group:
Data Mining and Modeling for Systems Biology and Pharmacology

Tero Aittokallio
tero.aittokallio[at]utu.fi

Department of Mathematics and Statistics,
University of Turku

www.fimm.fi/en/research/groups/aittokallio

Bioinformatics, Biomarker, Biomedicine, Breast cancer, Cancer, Cardiovascular diseases, Computer Science, Data mining, Diabetes, Disease models, Drug target, Genomics, Imaging, Machine learning, Metabolic diseases, Natural Compounds, Natural products, Ovarian cancer, Pattern recognition, Personalized medicine, Pharmacology, Point of care, Prostate cancer, Proteomics, Screening, Signaling, Synthetic Biology, Systems Biology, Target discovery

Research Group:
Cardiac Biomarkers

Saara Wittfooth
saara.wittfooth@utu.fi

Department of Biochemistry,
University of Turku

Saara Wittfooth

https://www.biocity.turku.fi/wp-content/uploads/2017/06/Wittfooth.pdf

Ageing-related diseases, Antibodies, Assay development, Autoimmune diseases, Biomarker, Biotechnology, Cardiovascular diseases, Clinical Chemistry, Clinical Medicine, In Vitro Diagnostics, Inflammation, Metabolic diseases, Obesity

Research Group:
Lyme borreliosis: A comprehensive approach

Jukka Hytönen
jukka.hytonen[at]utu.fi

Department of Medical Microbiology and Immunology,
University of Turku

Jukka Hytönen

Lyme borreliosis: a comprehensive approach

https://www.biocity.turku.fi/wp-content/uploads/2017/06/Hytonen.pdf

Antibodies, Assay development, Bacteriology, Biomarker, Biomedicine, Clinical Medicine, Disease models, Epidemiology, Genomics, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, PET, Point of care, X-ray crystallography

Research Group:
Enzymatic activity of gut bacteria in infancy and its impact on healthy microbiome

Arno Hänninen
arno.hanninen[at]utu.fi

Department of Medical Microbiology and Immunology,
University of Turku

Arno Hänninen

Microbiota and gut immune system in the pathogenesis of type 1 diabetes

https://www.biocity.turku.fi/wp-content/uploads/2017/06/Hanninen.pdf

Autoimmune diseases, Bacteriology, Bioinformatics, Biomarker, Clinical Medicine, Data mining, Diabetes, Immunology, In Vitro Diagnostics, Inflammation, Obesity, Personalized medicine

Research Group:
Kinase Function in Brain

Eleanor Coffey
ecoffey[at]btk.fi

Turku Centre for Biotechnology,
Åbo Akademi University and University of Turku

Eleanor Coffey

Kinase Function in Brain

Ageing-related diseases, Basic research, Biomarker, Biomedicine, Data mining, Disease models, Drug delivery, Drug target, In Vitro Diagnostics, Molecular Biology, Molecular diagnostics, Molecular modelling, Neurological disorders, PET, Proteomics, Screening, Signaling, Super-resolution imaging, Systems Biology, Target discovery